SCHEMBL899603

SCHEMBL899603

CCOc1cc(C(=O)O)cc(Cl)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.50
POLB P06746 2/20 0.43
ALOX15 P16050 1/20 0.43
HTT P42858 1/20 0.43
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.41
KMT2A Q03164 1/20 0.41
MCL1 Q07820 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
TSHR P16473 1/20 0.41
PDE4B Q07343 1/20 0.39
PDE4D Q08499 1/20 0.39
TPMT P51580 1/20 0.38
PLA2G2A P14555 1/20 0.38
PLAU P00749 1/20 0.38
PLA2G4B P0C869 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
BRD4 O60885 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19330178 0.89 MAPT (0.59) MAPTPOLBALOX15HTTTDP1
SCHEMBL15662782 0.87 KMT2A (0.45) MAPTHTTLMNAKMT2ATDP1
SCHEMBL10287469 0.86 PLA2G2A (0.49) POLBMEN1KMT2ATSHRPLA2G2A
SCHEMBL1314039 0.84 GPR119 (0.49) POLBMEN1KMT2ACYP2C9CYP2C19
SCHEMBL19330396 0.83 KDM4E (0.55) MAPTLMNATDP1TSHRPLA2G2A
SCHEMBL3714048 0.83 TAS1R3 (0.40) TPMTPLA2G2APLAU
SCHEMBL3216400 0.81 TAS1R3 (0.39) POLBGAAKMT2ATDP1TPMT
SCHEMBL1424858 0.81 MAPT (0.51) MAPTPOLBALOX15HTTLMNA
SCHEMBL19354063 0.81 MAPT (0.51) MAPTPOLBHTTMEN1LMNA
SCHEMBL837798 0.81 ALDH1A1 (0.56) POLBALOX15LMNATDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230322777-A1 N1-Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors PFIZER INC. (US) 2023-10-12 US disclosed
US-11673890-B2 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors PFIZER INC. (US) 2023-06-13 US disclosed
US-20210047325-A1 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS PFIZER INC. (US) 2021-02-18 US disclosed
US-10822335-B2 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors PFIZER INC. (US) 2020-11-03 US disclosed
US-20190218218-A1 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS PFIZER INC. (US) 2019-07-18 US disclosed
US-10294225-B2 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors PFIZER INC. (US) 2019-05-21 US disclosed
US-20180162858-A1 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS PFIZER INC. (US) 2018-06-14 US disclosed
US-9908883-B2 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors PFIZER INC. (US) 2018-03-06 US disclosed
US-9663511-B2 Sphingosine 1-phosphate receptor antagonists Arroyo BioSciences, LLC (US) 2017-05-30 US disclosed
US-9663511-B2 Sphingosine 1-phosphate receptor antagonists Arroyo BioSciences, LLC (US) 2017-05-30 US disclosed
US-8703797-B2 Condensed ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (S1P2) receptors ALLERGAN, INC. (US) 2014-04-22 US disclosed
US-20130296361-A1 Condensed Ring Pyridine Compounds As Subtype-Selective Modulators Of Sphingosine-1-Phosphate-2 (S1P2) Receptors ALLERGAN, INC. 2013-11-07 US disclosed
WO-2013148460-A1 NOVEL SPHINGOSINE 1-PHOSPHATE RECEPTOR ANTAGONISTS SWENSON ROLF E (US) 2013-10-03 WO disclosed
US-8507682-B2 Condensed ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (S1P2) receptors ALLERGAN, INC. (US) 2013-08-13 US disclosed
EP-2621493-A1 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS Pfizer Inc (US) 2013-08-07 EP disclosed
US-20130190334-A1 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS PFIZER INC. (US) 2013-07-25 US disclosed
US-20120208840-A1 Condensed Ring Pyridine Compounds As Subtype-Selective Modulators Of Sphingosine-1-Phosphate-2 (S1P2) Receptors ALLERGAN, INC. (US) 2012-08-16 US disclosed
EP-2483245-A1 CONDENSED RING PYRIDINE COMPOUNDS AS SUBTYPE-SELECTIVE MODULATORS OF SPHINGOSINE-1-PHOSPHATE-2 (S1P2) RECEPTORS Allergan, Inc. (US) 2012-08-08 EP disclosed
WO-2012042433-A1 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS PFIZER INC. (US) 2012-04-05 WO disclosed
WO-2011041287-A1 CONDENSED RING PYRIDINE COMPOUNDS AS SUBTYPE-SELECTIVE MODULATORS OF SPHINGOSINE-1-PHOSPHATE-2 (S1P2) RECEPTORS ALLERGAN, INC. (US) 2011-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130190334-A1 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS ACACA, ACACB, PC MAPT 1882/4885POLB 1613/4885ALOX15 1039/4885
US-20230322777-A1 N1-Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors ACACA, ACACB, PC MAPT 1409/4885POLB 1523/4885ALOX15 1340/4885
US-11673890-B2 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors ACACA, ACACB, PC MAPT 1417/4885POLB 1659/4885ALOX15 1337/4885
US-20190218218-A1 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS ACACA, ACACB, PC MAPT 1494/4885POLB 1639/4885ALOX15 1325/4885
US-20130296361-A1 Condensed Ring Pyridine Compounds As Subtype-Selective Modulators Of Sphingosine-1-Phosphate-2 (S1P2) Receptors S1PR1, S1PR2, S1PR3 MAPT 4756/4885POLB 3462/4885ALOX15 889/4885
US-10294225-B2 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors ACACA, ACACB, PC MAPT 1409/4885POLB 1523/4885ALOX15 1340/4885
US-20210047325-A1 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS ACACA, ACACB, PC MAPT 1417/4885POLB 1659/4885ALOX15 1337/4885
US-20120208840-A1 Condensed Ring Pyridine Compounds As Subtype-Selective Modulators Of Sphingosine-1-Phosphate-2 (S1P2) Receptors S1PR1, S1PR2, S1PR3 MAPT 4756/4885POLB 3462/4885ALOX15 889/4885
US-10822335-B2 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors ACACA, ACACB, PC MAPT 1409/4885POLB 1523/4885ALOX15 1340/4885
US-20180162858-A1 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS ACACA, ACACB, PC MAPT 1409/4885POLB 1523/4885ALOX15 1340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.